InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Benton Susan, 董事. Officer active across 2 companies, notably Ocuphire Pharma, Inc.. Aggregated, 13 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €77k. History available since 2 September 2021. The latest transaction was disclosed on 20 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Benton Susan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
24,367 股0Common StockSEC:0000905148-26-001784:0
79,504 股0Common StockSEC:0000905148-25-001426:0
41,143 股0Common StockSEC:0000905148-24-001710:0
19,418 股Common StockSEC:0001140361-24-000491:0
10,976 股0Common StockSEC:0001140361-23-029021:0
1,053 股Common StockSEC:0001140361-23-019676:0
16,267 股Common StockSEC:0001140361-23-001504:0
6,335 股Common StockSEC:0001140361-22-025289:0
3,395 股Common StockSEC:0001140361-22-013064:0
2,949 股Common StockSEC:0001140361-22-000658:0
2,135 股Common StockSEC:0001140361-21-033449:0
20,000 股@ US$4.57100.0% 占其流量Common StockSEC:0001140361-21-030364:0
标准退出：2021年12月1日 (T+90)
2,083 股Common StockSEC:0001140361-21-023335:0
13 条申报中的 13 条
About Benton Susan
Benton Susan is Administrateur at Ocuphire Pharma, Inc. and Opus Genetics, Inc. She has 13 filings in total, and across the recent filings tracked, the reported activity consists of purchases of EUR 76959 and no sales, from 2021-07-02 to 2026-04-22. The most frequent transaction nature is Attribution.
